Italian rider Diego Ulissi, who won two stages of this year`s Giro d`Italia, failed a drugs test during the race, his team Lampre confirmed on Wednesday.
|Last Updated: Jun 26, 2014, 03:31 AM IST|Source: AFP
Paris: Italian rider Diego Ulissi, who won two stages of this year`s Giro d`Italia, failed a drugs test during the race, his team Lampre confirmed on Wednesday.
The 24-year-old returned a positive test for salbutamol, a drug used to treat asthma, during the 11th stage on May 21 at Savone.
Lampre said that Ulissi had revealed to testers at the time that he had two puffs of ventolin containing salbutamol as well as paracetamol, following a fall during the stage.
The Tuscan rider has been suspended by his team pending the analysis of his B sample.
"Ulissi strongly rejects the presence of such a large amount of salbutamol," the team said in a statement.
Riders are permitted to use the drug for medical purposes below a certain threshold, but Ulissi`s sample contained almost twice the permitted concentration.
The statement continued: "The results of the test from the UCI report the presence in the urine of the athlete of an abnormal amount of salbutamol (1900 ng/ml), higher than the limit allowed by the regulations, which sees the limit at 1000 ng/ml.
"The athlete himself and the medical staff of the team will continue to explore the reasons why the urine has been identified as having an abnormal and high presence of salbutamol, compared to only two inhalations performed."
Ulissi won the fifth stage at Viggiano and the eighth at Montecopiolo, but quit the race after the 17th stage.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.